Pregnancy should not delay cancer treatment, study suggests
the ONA take:
Women whose cancer is diagnosed while pregnant can start cancer treatment immediately and do not need to terminate the pregnancy due to concerns over harm to the fetus, a new study published online ahead of print in The New England Journal of Medicine has shown.
For the international, case-control study, researchers compared children age 12 to 42 months who mothers received a cancer diagnosis during pregnancy with matched children of women without cancer.
Of the 129 children identified, 96 were exposed to chemotherapy, 11 to radiotherapy, 13 to surgery alone, and 2 to other drug treatment. Fourteen were not exposed to treatment.
Results showed that prenatal exposure to maternal cancer with or without treatment did not negatively affect cardiac, cognitive, or general development of children in early childhood.
"Our results show that fear of cancer treatment is no reason to terminate a pregnancy, that maternal treatment should not be delayed and that chemotherapy can be given. The study also shows that children suffer more from prematurity than from chemotherapy, so avoiding prematurity is more important than avoiding chemotherapy," said lead author Frédéric Amant, MD, PhD, a gynecological oncologist at the University Hospitals Leuven in Belgium and at Antoni van Leeuwenhoek in The Netherlands.
Women whose cancer is diagnosed while pregnant can start cancer treatment immediately and do not need to terminate the pregnancy.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Aligning Patient Goals With End of Life Treatment Decisions
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
- Increased Diabetes Risk Associated With Cancer Development
- Childhood Neuroblastoma Survivors at Risk for Psych Impairment
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|